The acquisition expands access to local grain and strengthens Kalmbach’s feed, pet food and ingredient operations.
High feed costs, limited access to quality fish seed and weak fish health systems are among the key barriers to aquaculture growth.
The interim financing was oversubscribed with participation from private investors, family offices, and venture capital across the UK, Norway, and the European Union.
The site expansion bolsters Elanco’s monoclonal antibody (mAb) production; supports delivery of next-generation pipeline.
The project was officially opened on August 5, with representatives from Imas attending the ceremony.
Haid is investing in local production capacity in markets where livestock and aquaculture sectors are expanding.
The project will repurpose a 463,503-square-foot fermentation facility at ADM’s Clinton complex.
The acquisition gives BiomEdit control of Folium’s Guided Biotics CRISPR-Cas technology and BiomElix One.
The facility is expected to open by the end of 2026.
The Nordic-focused fund will finance pre-seed to Series A companies developing maritime and ocean technologies.